Search 25,000+ prices/

Atorvastatin Price by Country (2026)

Compiled by the TrustClinix data team · Medical review pending7 official sourcesPrices last checked 25 October 2026How we get our data

$0.010 – $0.24 per unit

Official 2026 prices for atorvastatin 10 mg tablet in India, the United States, the United Kingdom, Australia, South Africa and the UAE, converted to US dollars.

Atorvastatin is a statin that lowers LDL ('bad') cholesterol and reduces the risk of heart attack and stroke.

Atorvastatin 10 mg tablet: price by country

Price by country
CountryPrice typeLocal price per unitPer unit (USD)30 units (USD)
IndiaJan Aushadhi retail price (MRP)₹0.91$0.010$0.29
United StatesPharmacy acquisition cost (NADAC)$0.023$0.023$0.69
United KingdomNHS Drug Tariff reimbursement price£0.024$0.032$0.96
AustraliaPBS approved ex-manufacturer priceA$0.083$0.058$1.75
South AfricaSingle Exit Price (SEP)R0.99$0.059$1.78
United Arab EmiratesAbu Dhabi DoH public priceAED 0.87$0.24$7.08
India$0.010
United States$0.023
United Kingdom$0.032
Australia$0.058
South Africa$0.059
United Arab Emirates$0.24
Atorvastatin 10 mg tablet: price per unit by country (USD)

Each country publishes a different type of price, explained on each country page. Converted at ECB reference rates of 23 October 2026.

More countries

Atorvastatin prices in South Africa, the UAE, Saudi Arabia, Australia, the United Kingdom and the United States

About atorvastatin

Atorvastatin is the most commonly prescribed statin and is usually taken once a day, at any time. The dose ranges from 10 mg to 80 mg depending on how much cholesterol needs to be lowered and the person's heart risk. Muscle aches are the best-known side effect. Generic atorvastatin replaced the brand Lipitor in most markets and is far cheaper.

Drug class: Statin (cholesterol lowering). Used for: high cholesterol and coronary artery disease.

Quick answers

Frequently asked questions

How much does atorvastatin cost?
Atorvastatin 10 mg tablet costs between $0.010 and $0.24 per unit in the countries we cover, based on official price lists.
Evidence

Sources

  1. Pharmaceuticals & Medical Devices Bureau of India (PMBI), Department of Pharmaceuticals, Government of India. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) Product & MRP List. janaushadhi.gov.in/product-portfolio/product-mrp-list. Retrieved 25 October 2026.
  2. Centers for Medicare & Medicaid Services (CMS). NADAC (National Average Drug Acquisition Cost) 2026 (as of 2026-10-21). data.medicaid.gov/dataset/fbb83258-11c7-47f5-8b18-5f8e79f7e704. Retrieved 25 October 2026.
  3. NHS Business Services Authority (NHSBSA). Drug Tariff Part VIIIA Category M prices - October 2026. www.nhsbsa.nhs.uk/sites/default/files/2026-09/Cat%20M%20Prices%20-%20Q. Retrieved 25 October 2026.
  4. Australian Government Department of Health, Disability and Ageing. Pharmaceutical Benefits Scheme (PBS) Schedule, 1 October 2026 (PBS API). www.pbs.gov.au/. Retrieved 25 October 2026.
  5. National Department of Health, South Africa. Database of Medicine Prices (Single Exit Price), effective 1 October 2026. www.health.gov.za/nhi-pee/. Retrieved 25 October 2026.
  6. Department of Health – Abu Dhabi. Drug Master price list (public prices), version effective 2 October 2026. www.doh.gov.ae/en/resources/drug-prices. Retrieved 25 October 2026.
  7. European Central Bank. Euro foreign exchange reference rates (2026-10-23). www.ecb.europa.eu/stats/eurofxref/eurofxref-daily.xml. Retrieved 25 October 2026.

Important: These are published reference prices and estimates, not a quote, and not medical advice. Actual costs depend on the hospital, your health, the exact treatment and your insurance. Always confirm the price with the provider before treatment. Read our disclaimer · Report an error

Related medicines